Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,816 | 20,801 | 21,825 | 26,332 | 24,613 |
| Receivables | 12,308 | 8,868 | 8,066 | 8,619 | 8,869 |
| Inventories | 17,137 | 17,660 | 16,167 | 17,135 | 17,708 |
| Income taxes - deferred | 478 | 551 | 555 | 530 | 391 |
| Other current assets | 981 | 1,186 | 917 | 1,029 | 889 |
| TOTAL | $53,720 | $49,066 | $47,530 | $53,645 | $52,470 |
| Non-Current Assets | |||||
| PPE Net | 4,922 | 4,904 | 4,973 | 5,098 | 4,860 |
| Intangibles | 24,194 | 24,419 | 24,648 | 24,880 | 25,129 |
| Other Non-Current Assets | 250 | 246 | 248 | 250 | 255 |
| TOTAL | $29,366 | $29,569 | $29,869 | $30,228 | $30,244 |
| Total Assets | $83,086 | $78,635 | $77,399 | $83,873 | $82,714 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,295 | 1,505 | 1,754 | 1,570 | 1,890 |
| Accrued Expenses | 3,712 | 2,026 | 1,652 | 2,181 | 2,735 |
| Other current liabilities | 1,715 | 1,400 | 285 | 2,400 | 1,700 |
| TOTAL | $8,398 | $5,535 | $3,775 | $7,582 | $7,167 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,600 | 1,415 | 2,815 | 2,600 | 3,300 |
| TOTAL | $3,979 | $3,873 | $5,230 | $5,094 | $5,729 |
| Total Liabilities | $12,377 | $9,408 | $9,005 | $12,676 | $12,896 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,661 | 8,626 | 8,624 | 8,597 | 8,591 |
| Common Shares | 32,210 | 32,038 | 31,982 | 31,570 | 31,294 |
| Retained earnings | 40,425 | 39,115 | 38,338 | 41,553 | 40,450 |
| Other shareholders' equity | 74 | 74 | 74 | 74 | 74 |
| TOTAL | $70,709 | $69,227 | $68,394 | $71,197 | $69,818 |
| Total Liabilities And Equity | $83,086 | $78,635 | $77,399 | $83,873 | $82,714 |